Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
- PMID: 22198732
- DOI: 10.1038/nchembio.761
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
Abstract
Until now, a lack of inhibitors with high potency and selectivity in vivo has hampered investigation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We describe the design of skepinone-L, which is, to our knowledge, the first ATP-competitive p38 MAPK inhibitor with excellent in vivo efficacy and selectivity. Therefore, skepinone-L is a valuable probe for chemical biology research, and it may foster the development of a unique class of kinase inhibitors.
Similar articles
-
Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.Cell Physiol Biochem. 2013;31(6):914-24. doi: 10.1159/000350110. Epub 2013 Jun 18. Cell Physiol Biochem. 2013. PMID: 23817201
-
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis.Inflammopharmacology. 2019 Dec;27(6):1217-1227. doi: 10.1007/s10787-019-00593-6. Epub 2019 Apr 29. Inflammopharmacology. 2019. PMID: 31037574
-
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity.J Med Chem. 2013 Jan 10;56(1):241-53. doi: 10.1021/jm301539x. Epub 2012 Dec 27. J Med Chem. 2013. PMID: 23270382
-
Novel strategies for inhibition of the p38 MAPK pathway.Trends Pharmacol Sci. 2007 Jun;28(6):286-95. doi: 10.1016/j.tips.2007.04.008. Epub 2007 May 7. Trends Pharmacol Sci. 2007. PMID: 17482683 Review.
-
p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.Curr Top Med Chem. 2013;13(9):1015-35. doi: 10.2174/1568026611313090005. Curr Top Med Chem. 2013. PMID: 23651481 Review.
Cited by
-
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.Mol Cancer Ther. 2019 Sep;18(9):1506-1519. doi: 10.1158/1535-7163.MCT-18-0571. Epub 2019 Jun 18. Mol Cancer Ther. 2019. PMID: 31213506 Free PMC article.
-
Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.PLoS One. 2016 Feb 4;11(2):e0148574. doi: 10.1371/journal.pone.0148574. eCollection 2016. PLoS One. 2016. PMID: 26845024 Free PMC article.
-
Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding.Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2546-51. doi: 10.1073/pnas.1216182110. Epub 2013 Jan 28. Proc Natl Acad Sci U S A. 2013. PMID: 23359699 Free PMC article.
-
A public-private partnership to unlock the untargeted kinome.Nat Chem Biol. 2013 Jan;9(1):3-6. doi: 10.1038/nchembio.1113. Nat Chem Biol. 2013. PMID: 23238671 No abstract available.
-
Candida albicans-induced leukotriene biosynthesis in neutrophils is restricted to the hyphal morphology.FASEB J. 2021 Oct;35(10):e21820. doi: 10.1096/fj.202100516RR. FASEB J. 2021. PMID: 34569657 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- PubChem-Substance/131287876
- PubChem-Substance/131287877
- PubChem-Substance/131287878
- PubChem-Substance/131287879
- PubChem-Substance/131287880
- PubChem-Substance/131287881
- PubChem-Substance/131287882
- PubChem-Substance/131287883
- PubChem-Substance/131287884
- PubChem-Substance/131287885
- PubChem-Substance/131287886
- PubChem-Substance/131287887
- PubChem-Substance/131287888
LinkOut - more resources
Full Text Sources
Other Literature Sources